Rich returns with another company profile. This time he’s moving outside the cannabis space to highlight an exciting company that’s straddling two huge markets. That company is Else Nutrition Holdings Inc. (TSXV:BABY) (OTCPK:BABYF).
Else Nutrition is a food and nutrition company focusing on researching, developing, manufacturing, marketing, selling, and/or licensing plant-based food and nutrition products. The products are targeted for the infant, toddler, children, and adult markets.
“I think that this company has a great future and huge potential,” says Rich. “I absolutely love this company.”
What Makes Else Nutrition Unique?
What sets Else Nutrition apart from competitors is its 100% plant-based, non-soy alternative to dairy-based baby formula.
This formula is the first of its kind on the market. Made from almonds and buckwheat, it’s free of GMOs, pesticides, hormones, antibiotics, gluten, and phytoestrogens. This means it is a healthier and more natural option for toddlers (12–36 months) as a real alternative to dairy-based baby formulas.
Because it doesn’t use dairy or soy, Else Nutrition’s formula is the best solution for babies who are lactose intolerant and/or have other sensitivities that keep them from experiencing the benefit of existing products.
“This company could change the world, and that’s why I wanted to bring it to you first,” Rich explains.
The reason Else’s formula is such a novel innovation in the industry is that, right now, the vast majority of infant formulas are milk-based. Yet cow’s milk is the number one allergen for children aged five or younger. Milk allergies currently affect half of food-allergic children in America who are less than one year old.
As for the other non-dairy alternatives, nearly all of them are soy-based. But approximately 40% percent of children allergic to cow’s milk are also allergic to soy milk.
What this means is that there are entire segments of the population that can’t drink either cow’s milk nor any of the alternatives except for Else Nutrition’s 100% plant-based formula. This kind of exclusive market reach is unprecedented, especially in a market as important as children’s health and nutrition.
“If you’re a parent and you want your kids to be healthy, you need to move away from milk,” says Rich. “You need to get into plant-based nutrition.”
Else Nutrition’s Two Huge Markets
According to a report from Hexa Research, the global market for infant formula is expected to exceed $90 billion USD by 2025 with a CAGR of 9.35%. This growth is being driven largely by the introduction of milk formulas with additional nutrition, such as the Else Nutrition 100% plant-based formula.
The other market that Else is ready to disrupt is the plant-based foods market. Companies like Beyond Meat (NASDAQ:BYND) have been doing exceptionally well this year, but have yet to target children’s food or infant formulas.
Data from the Plant Based Foods Association and The Good Food Institute reveals that sales of plant-based foods have grown 11 percent across America in the past year. The US market for 2019 is valued at $4.5 billion and is likely to continue to grow at a similar rate.
Else Nutrition debuted on the TSX Venture Exchange in June at $0.69 and has since fallen to $0.33. The company plans to begin releasing its products in the US beginning next spring.
“In my opinion this stock is near a 52-week low and this is the time to buy,” says Rich.
What do you think? Is Else Nutrition an important stock to watch in the coming months? If you liked this video, be sure to check out Rich’s other company profiles of Green Growth Brands (CSE:GGB) (OTCQB:GGBXF) and Victory Square Technologies (CSE:VST) (OTCQX:VSQTF).
Featured image: DepositPhotos © Ipatov
